Has Anita Fletcher, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,266 in general payments to Anita Fletcher, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anita Fletcher, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anita Fletcher, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anita Fletcher, MD

Neurology · Orlando, FLNPI 1023470176

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,203 of the $12,266 with a category attached, or 91.3%. Sanofi accounts for 94.1% of it on its own, with 7 other manufacturers making up the rest.

$12,266in general payments, 2019–2025

Across 24 payments — averaging $511.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$12K
AbbVie$150
TG Therapeutics, Inc.$141
Biogen$137
Genentech, Inc.$102
Amgen$86
plus $108 from 2 others

$324,527in research payments, 2019–2025

Across 15 payments — averaging $21,635 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$261K
Genentech, Inc.$44K
Sanofi US Services Inc.$20K
Novartis Pharma AG$19

What the payments were for

Consulting fees$11,20391%
Travel & lodging$2562%
Food & beverage$8087%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	4	$11,541
AbbVie	11	$150
TG Therapeutics, Inc.	2	$141
Biogen	2	$137
Genentech, Inc.	1	$102
Amgen	2	$86
E.r. Squibb & Sons, L.L.C.	1	$72
Microtransponder, Inc.	1	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BRIUMVI$119
OCREVUS$102

How this compares

$12,266 in reported general payments places this provider in the 75th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$19,615

Medicare patients

Services billed

126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CopaxoneGlatiramer Acetate	14	$79,362
Pregabalin	31	$1,111
Baclofen	27	$694
Gabapentin	24	$658
Levetiracetam	14	$360
Cyclobenzaprine Hcl	11	$95
Topiramate	11	$62
Methocarbamol	11	$32

Paid to pharmacies, not to this prescriber.

Other neurology in Orlando

Ramon Rodriguez CruzOrlando$1M
Mark KlafterOrlando$247K
Stuart IsaacsonBoca Raton$3.9M
Selim BenbadisTampa$2.1M
Derrick RobertsonTampa$1.8M
Robert HauserTampa$1.6M
David RoseTampa$1.4M
Matthew BakerNaples$1.4M
Donald NegroskiSarasota$1.4M
Mark CascioneTampa$1.2M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →